Understanding Pharmacogenomics - Personalizing Medicine

PRLog (Press Release) - Apr 01, 2009 -
Phoenix, AZ – “Understanding Pharmacogenomics,” published by Pharma-Reports.com, examines the basics of pharmacogenomics and analyzes how drug development and drug discovery processes are affected by pharmacogenomics.

The report covers the economics of developing pharmacogenomics to aid drug development, the various impacts pharmacogenomics is to have on the healthcare industry in general, and much more. The report is a guide to the developing world of pharmacogenomics and how it is impacting every field of healthcare.

Pharmacogenomics is the branch of pharmacology, which deals with the influence of genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms (SNPs) with a drug's efficacy or toxicity. By doing so, pharmacogenomics aims to develop rational means to optimize drug therapy, with respect to the patients' genotype, to ensure maximum efficacy with minimal adverse effects. Such approaches promise the advent of "personalized medicine", in which drugs and drug combinations are optimized for each individual's unique genetic makeup.

Other Topics covered in this report include: Drug Characteristics, Drug  Targets, and Side Effects of Pharmacogenomics; Challenges Facing Pharmacogenomic Development; Pharmacogenetics and Regulatory Issues; and Assessing the Cost Effectiveness of Pharmacogenomics.
.
About the Publisher: "Understanding Pharmacogenomics " is published by Pharma-Reports (www.Pharma-Reports.com), a pharmaceutical and biotechnology industry think tank and leading source for pharmaceutical and biotechnology industry information and research products. View details of this report at http://www.pharma-reports.com/shop/item.asp?itemid=7&affi...

Photo:
http://www.prlog.org/10193964/1